论文部分内容阅读
一项新的研究结果表明,辛伐他汀(simvastatin)可显著降低修饰的低密度脂蛋白(mLDL)的结果暗示对治疗2型糖尿病患者冠状动脉粥样硬化的炎性组分具有一定的潜在益处。尽管糖尿病可加速患者动脉粥样硬化及心血管事件的发生已得到公认,但是人们对该作用机理的发生尚不完全明确。研究人
A new study shows that simvastatin can significantly reduce the results of modified low density lipoprotein (mLDL) implies some potential benefits for the treatment of coronary atherosclerosis inflammatory components in patients with type 2 diabetes . Although diabetes can accelerate the occurrence of atherosclerosis and cardiovascular events in patients has been recognized, but the mechanism of this action is not yet fully understood. Researcher